<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Serum concentrations of galectin-3 in patients with cardiac syndrome X

Loading...
Thumbnail Image

Departments

Item type:Organizational Unit,

School / College / Institute

Item type:Organizational Unit,
SCHOOL OF MEDICINE
Upper Org Unit

Program

Organization Authors

Co-Authors

Polat, Veli

Açıksarı, Gönül

Opan, Selçuk

Bayrak, İbrahim Halil

Paker, Nurcan

Karakaya, Osman

Date

Language

Embargo Status

N/A

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Objective: Microvascular dysfunction has been reported in cardiac syndrome X (CSX), even though the underlying mechanisms still remain uncertain. Galectin-3 has been recently recognized as a biomarker of cardiovascular fibrosis and inflammation. We sought to investigate the role of galectin-3 in the CSX. Methods: We studied 115 consecutive CSX patients (mean age 55.43±8.71 years, 36 men) and 74 healthy controls (mean age 54.53±10.07 years, 31 men). Serum concentrations of galectin-3 and high-sensitive C-reactive protein (hs-CRP) were measured on the blood samples. Results: Galectin-3 concentrations were significantly higher in patients with CSX compared to controls (0.90ng/ml; IQR, 0.40-1.70ng/ml vs 0.40ng/ml; IQR, 0.36-0.44ng/ml, p<0.0001). Although, the prevalence of diabetes mellitus, hypertension and family history of coronary artery disease (CAD) were significantly higher among patients with CSX, following adjustment for diabetes mellitus, hypertension, and family history of CAD, serum galectin-3 concentrations were still found significantly increased in patients with CSX. Galectin-3 concentrations correlated positively with hs-CRP (. r=0.16, p=0.03). In addition, concentrations of galectin-3, hs-CRP, fasting glucose, uric acid and family history of CAD were determined as independent predictors of the CSX. Conclusion: It was found that galectin-3 serum concentrations are higher in patients with CSX compared to healthy controls. Further studies on larger population are needed to confirm the relation between the fibrosis and the CSX, as well as to explore the potential role of galectin-3 in the CSX. © 2014 Elsevier Ireland Ltd.

Source

Publisher

Elsevier

Citation

item.page.haspartof

Source

Atherosclerosis

item.page.ispartofseries

item.page.edition

DOI

10.1016/j.atherosclerosis.2014.09.014

item.page.datauri

item.page.link

Rights

N/A

Copyrights Note

Rights and licensing

N/A

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Item type:Goal, Access status: Open Access ,
03 - Good Health and Well-being
Over the last 15 years, the number of childhood deaths has been cut in half. This proves that it is possible to win the fight against almost every disease. Still, we are spending an astonishing amount of money and resources on treating illnesses that are surprisingly easy to prevent. The new goal for worldwide Good Health promotes healthy lifestyles, preventive measures and modern, efficient healthcare for everyone.
Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators